This study showed that ALR-S significantly inhibited FeCl3-induced arterial thrombosis in rats by rebalancing the abovementioned thrombotic/antithrombotic factors, including vWF, TF, TXB2 (the metabolite of TXA2), 6-keto-PGF1α (the metabolite of PGI2), TM, TFPI, and PECAM-1. The gene discussed is TFPI; the disease is Arterial thrombosis.